Target intelligence / Profile preview

Oxalate:formate antiporter (OxlT)

Target
OxlT
Molecular classification
Transporter, Major facilitator superfamily (MFS) transporter
01

Overview

Oxalate:formate antiporter, commonly known as OxlT, is a membrane transporter found in the obligate anaerobic, oxalate-degrading bacterium Oxalobacter formigenes[1][2][4]. It belongs to the major facilitator superfamily (MFS) of transporters and is composed of 12 transmembrane helices[4][6]. OxlT catalyzes the exchange of divalent oxalate ions (from the intestinal lumen) for monovalent formate ions (produced internally by oxalate decarboxylation), a process crucial for the bacterium's energy metabolism and symbiotic relationship with the human host[1][4][6]. The antiport activity helps generate a proton motive force that drives bacterial ATP synthesis through substrate-level phosphorylation, with Lys-355 identified as a key residue for substrate binding and transport[5]. Structural studies have resolved OxlT in both oxalate-bound and ligand-free states, revealing a V-shaped cavity involved in substrate translocation[1][8]. OxlT is not a direct drug target, but its role in oxalate metabolism has made Oxalobacter formigenes a focus of research into lowering intestinal oxalate absorption, which may indirectly affect kidney stone (nephrolithiasis) risk[1][2][4][6].

Other names
Oxalate transporterOxlT proteinoxalate/formate antiporterOFA transporter
02

Mechanism of action

Facilitates the exchange (antiport) of extracellular oxalate (import) and intracellular formate (export) across the cytoplasmic membrane of Oxalobacter formigenes[1][4][6]. - Drives metabolic proton motive force via electrogenic exchange and metabolic coupling[1][4][6].

03

Biological functions

Oxalate transportFormate exportGeneration of proton motive forceEnergy metabolism
04

Disease associations

Other (not directly linked to human disease, but of interest for oxalate metabolism and nephrolithiasis risk due to Oxalobacter formigenes role in human gut)
05

Safety considerations

None reported (OxlT is a bacterial membrane transporter in O. formigenes, with no direct therapeutic targeting or toxicity known in humans)
06

Interacting drugs

None known (no small molecule inhibitors or drugs targeting OxlT directly reported in literature)
07

Biomarkers

Presence or abundance of Oxalobacter formigenes (which expresses OxlT), sometimes assessed as a biomarker in studies of oxalate metabolism and kidney stone risk in humans, not specific to OxlT protein itself.

Beyond the preview

Go deeper on Oxalate:formate antiporter (OxlT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxalate:formate antiporter (OxlT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call